Amgen

Gilead Sciences

Vertex Pharmaceuticals

Regeneron Pharmaceuticals

IQVIA Hlds

Illumina

Natera

Biogen

ICON

Alnylam Pharmaceuticals

VanEck Vectors Biotech ETF

BBH tracks a market-cap-weighted index of the 25 largest biotech firms globally.

Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund launched on 12/20/2011.

Should You Invest in the VanEck Biotech ETF (BBH)?

Biotechnology sector experiencing exponential growth driven by emerging technologies addressing global challenges. VanEck Biotech ETF tracks top U.S.-listed biotech companies, offers exposure to innovative therapies and technologies. BBH is under-discovered compared to peers, offers potential for trend change in favor of biotech sector.

BBH: Buy Rating, As Tech Investors Look Beyond FAANG

Corcept Therapeutics

Royalty Pharma

I'm on the hunt for ‘Strong Buy' biotech stocks.  According to Finviz.com, there are 680 U.S.-listed biotech stocks.

Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for June 2024

VanEck Biotech ETF BBH is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and moved up 21.4% from its 52-week low price of $142.51/share.

Biotech ETF (BBH) Hits New 52-Week High

BOSTON--(BUSINESS WIRE)--As the ETF industry reaches a milestone of $12.71 trillion in global assets, the Brown Brothers Harriman 2024 Global ETF Investor Survey finds that investors plan to further increase their use of ETFs in the next year, while also expanding the number of ETF providers they invest with. Active ETFs, which have grown at a staggering 38.4%i annual rate over the past 10 years, will continue to be a focus for ETF investors as they seek downside protection while pursuing new a.

ETF Investors Indicate Active Strategies and Product Innovation Will Fuel the Industry's Continued Growth: BBH 2024 Global ETF Investor Survey

iShares Nasdaq Biotechnology ETF

Health Care Select Sector SPDR Fund

Jared Ablass, Vice President, Portfolio Research at TD Asset Management, speaks with Greg Bonnell about how the biotech sector could benefit once rates start to come down. Why beaten down Biotech stocks could be ready for a healthy recovery.

Why Biotech Stocks May Be Ready For A Recovery

Invesco Dynamic Biotechnology & Genome ETF

SPDR S&P Biotech ETF

Look into how Biotech ETFs performed after Q4 earnings.

Where Are Biotech ETFs Headed After Q4 Earnings?

Virtus LifeSci Biotech Products ETF

Bristol-Myers

Invesco Nasdaq Biotechnology ETF

Johnson & Johnson

Merck

The biotech space staged a strong comeback at the start of 2024, driven by multi-billion dollar deals, upbeat clinical results and cutting-edge medical advances like CRISPR gene-editing hitting prime-time.

Biotech ETFs Stage Solid Comeback at the Start of 2024

Generative artificial intelligence was a point of emphasis for investors in 2023. That movement is just getting started.

AI Advancements Could Be Boon for Biotech Industry

VanEck Vectors Africa Index ETF

VanEck Vectors Gaming ETF

VanEck Vectors Brazil Small-Cap ETF

VanEck Vectors Social Sentiment ETF

Vaneck Cmci Commodity Strategy Etf

VanEck Vectors ChinaAMC SME-ChiNext ETF

VanEck Vectors Oil Refiners ETF

VanEck Vectors Digital Transformation ETF

Vaneck Digital India ETF

VanEck Vectors Egypt Index ETF

VanEck Video Gaming and eSports ETF

VanEck Vectors Environmental Services ETF 

VanEck Vectors Gold Miners ETF

VanEck Junior Gold Miners ETF

VanEck Green Metals ETF

VanEck Vectors Natural Resource ETF

VanEck Robotics ETF

VanEck Vectors Indonesia Index ETF

VanEck Vectors Israel ETF

VanEck Morningstar Wide Moat ETF

VanEck Vectors Agribusiness ETF

Vaneck Morningstar ESG Moat ETF

VanEck Morningstar Global Wide Moat ETF

VanEck Vectors Morningstar International Moat ETF

VanEck Vectors Uranium+Nuclear Energy ETF

VanEck Vectors Oil Services ETF

VanEck Commodity Strategy ETF

VanEck Rare Earth/Strategic Metals ETF

Vaneck Green Infrastructure ETF

VanEck Vectors Russia ETF

VanEck Vectors Russia Small-Cap ETF

VanEck Vectors Retail ETF

VanEck Vectors Steel ETF

VanEck Vectors Semiconductor ETF

VanEck Low Carbon Energy ETF

Vaneck Morningstar SMID Moat ETF

VanEck Vectors Vietnam ETF

VanEck Future of Food ETF

NEW YORK--(BUSINESS WIRE)--VanEck announced today the 2023 annual distributions per share for its VanEck® equity exchange-traded funds.

VanEck Announces Year-End Distributions for VanEck Equity ETFs

Biotech sector has potential for outperformance in the next year. VanEck Biotech ETF is a good product to consider for exposure to the sector. BBH focuses on large-cap biotech stocks, offering a more balanced choice with better risk-adjusted returns.

BBH: A Solid Way To Play A Comeback In Biotech

Alerian MLP ETF

ARK Genomic Revolution Multi-Sector ETF

Amplify Lithium & Battery Technology ETF

SPDR Bloomberg 1-3 Month T-Bill ETF

PIMCO Active Bond ETF

Amplify Seymour Cannabis ETF

Global X Autonomous & Electric Vehicles ETF

Alerian Energy Infrastructure ETF

First Trust Global Wind Energy ETF

Global X Genomics & Biotechnology ETF

iShares Core High Dividend ETF

iShares Global Clean Energy ETF

iShares Core S&P Small Cap ETF

iShares U.S. Home Construction ETF

iShares Russell 2000 ETF

Adasina Social Justice All Cap Global ETF

KraneShares Electric Vehicles & Future Mobility Index ETF

KraneShares Global Carbon ETF

Global X Lithium & Battery Tech ETF

PIMCO Enhanced Short Maturity Active ETF

Invesco Dynamic Building & Construction ETF

First Trust NASDAQ Clean Edge Green Energy Index Fund

Invesco S&P 500 Equal Weight ETF

Good morning, VettaFi Voices! We are a week out from the VettaFi 2024 Market Outlook Symposium on December 14, which will feature a range of ETF industry leaders discussing their expectations for different areas of the financial markets and the economy in 2024.

VettaFi Voices On: The Outlook for 2024

VanEck Biotech ETF has outperformed alternative industry ETFs in recent years through its concentration in large-cap leaders. Biotech companies are benefiting from new artificial intelligence tools set to streamline and accelerate R&D programs. We are bullish on biotech stocks, which benefit from significant long-term growth opportunities.

BBH: Our Favorite Biotech ETF Can Keep Outperforming

Invesco Dynamic Pharmaceuticals ETF

Bank of America expects the Gilead Sciences to jump about 30%, as quoted on CNBC.

Time for Gilead Sciences-Heavy ETFs?

In what feels like an eternity in biotechnology terms, broader baskets of the industry's stocks haven't outperformed the S&P 500 Health Care Index annually since 2020. That streak could end this year, but biotech stocks and ETFs still aren't on fire.

Biotech Still Has Disruptive Capabilities

Look if it's the right time to invest in biotech ETFs to help diversify your portfolio.

Is Now the Right Time to Embrace Biotech ETFs?

First Trust Morningstar Dividend Leaders Index Fund

First Trust Nasdaq Pharmaceuticals ETF 

Amplify Treatments Testing & Advancements ETF

Horizon Kinetics Medical ETF

Moderna

Novavax

Pfizer

The FDA advised to Pfizer, Moderna and Novavax to manufacture single-strain jabs targeting the omicron subvariant XBB.1.5 should prove to be a victory for some biotech ETFs.

Biotech ETFs in Focus on Covid Vaccines' Fall Rollout

Historically, biotechnology stocks trade at premiums relative to the healthcare and the broader market. That's simply the price of admission investors to pay to access the attractive growth prospects of biotech.

Bevy of Biotech Bargains in BBH

There are several choices for investors interested in biotech exposure through an ETF. Data analysis shows that biotech ETF returns are more sensitive to timing than the S&P500 and have higher probabilities for negative returns.

BBH: A Solid Choice For Biotech Exposure

ACADIA Pharma

Agios Pharmaceuticals

BioMarin Pharmaceutical

CareDx

Exact Sciences

Exelixis

First Trust NYSE Arca Biotechnology Index Fund

FibroGen

Ionis Pharma

Madrigal Pharmaceuticals

Pacific Biosciences of California

Seagen

Teladoc

TG Therapeutics

Here are the five best biotech ETFs to invest in right now.

Investing in Biotech ETFs

With generative artificial intelligence (AI) seemingly gaining traction by the day, more market participants are evaluating where this innovation fits into their industries. Biotech may be next for disruption.

Biotech Industry Ripe for AI Disruption

Earlier this month, VanEck launched the VanEck Robotics ETF (IBOT), a thematic equity ETF offering exposure to the leading global companies that are driving and benefiting from the growth of the robotics industry.

VanEck's John Patrick Lee Talks Trends Driving Robotics & IBOT

VanEck launched the VanEck Robotics ETF (IBOT), a thematic equity ETF offering exposure to the leading global companies that are driving and benefiting from the growth of the robotics industry. The fund trades on the Nasdaq.

VanEck Launches Robotics ETF

Simplify Health Care ETF

Sanofi

Shares of drugmakers Sanofi and Regeneron surged more than 6% on Mar 23 on COPD drug data.

ETFs in Focus on Sanofi and Regeneron's COPD Drug Data

Virtus LifeSci Biotech Clinical Trials ETF

iShares U.S. Pharmaceuticals ETF

iShares U.S. Healthcare Providers ETF

iShares U.S. Medical Devices ETF

iShares U.S. Healthcare ETF

VanEck Vectors Pharmaceutical ETF

Invesco S&P 500 Equal Weight Health Care ETF

Vanguard Health Care ETF

SPDR S&P Pharmaceuticals ETF

How SVB's collapse is impacting healthcare startups. Pfizer to buy Seagen for $43B.

The Fall Of SVB: What It Means For Healthcare Startups

News for VanEck Vectors Biotech ETF ETF (BBH)